Botany without borders: barcoding in focus

This recent meeting, held on the campus of the University of British Columbia, attracted 1200 delegates and a vast array of talks, but was notable for a remarkable showing of talks and posters on DNA barcoding in plants, spread through many sessions. The Canadian Centre for DNA Barcoding defines barcoding as ‘species identification and discovery through the analysis of short, standardized gene regions known as DNA barcodes’. This approach is somewhat controversial in animals ( Rubinoff et al., 2006 ), although it has been shown to be useful and reliable in many metazoan taxa ( Meyer & Paulay 2005 ; Hajibabaei et al., 2007 ), in which the mitochondrial cytochrome oxidase I (COI) gene is used. However, in land plants, COI evolves far too slowly to be useful, and there is no obvious single universal alternative ( Fazekas et al., 2008 ). Genes that work well in one taxon may perform poorly in other taxa. Additionally, some perfectly good plant species, reproductively isolated and morphologically and ecologically distinct, are too young to show much sequence divergence at most loci. Nevertheless, as we saw at this conference, progress has been made towards identifying genes that serve many of the functions of DNA barcodes, at least in some plant taxa.     

History of the Study of Biodiversity of Photosynthetic Bacteria

The tendencies in the study of anoxygenic photosynthetic bacteria (APB) are considered in the review in the historical aspect, from the discovery of APB till the present day. The contribution made by the researchers of the Institute of Microbiology, Russian Academy of Sciences, to the study of the phylogeny, ecology, and morphophysiological diversity of APB is noted. At present, molecular biological approaches play a decisive role in ecology and taxonomy. The most important task at the modern stage of the development of microbiology is to maintain the continuity of the historically formed classical approaches in the study of APB diversity.     

Future questions in insect chitin biology: A microreview

This microreview stems from the Second Symposium on Insect Molecular Toxicology and Chitin Metabolism held at Shanxi University in Taiyuan, China (June 27 to 30, 2017) at the institute for Applied Biology headed by Professor Enbo Ma and Professor Jianzhen Zhang.     

New Asteraceae from Mexico and Bolivia

Routine identification of Asteraceae specimens sent to the Herbarium of the University of Texas at Austin has resulted in the discovery of the following taxa:Acourtia ciprianoi (Mutisieae) andCoreopsis bolanosana andVerbesina spooneri (both Heliantheae). All the new species are illustrated.     

Lansing man: a half century later

One of the major fossil man finds from the Plains Area of the United States and one of the few from Kansas are the “Lansing Man” skeletons. The discovery was in February 1902 on the west bank of the Missouri River, south of Leavenworth near the town of Lansing, Kansas. Much was written about this skeleton following its discovery and Ale? Hrdli?ka's only trip to Kansas in October 1902 was to observe the skeletons and the site of its discovery. Numerous articles were written suggesting that “Lansing Man” was many thousands of years old. Geologists could not agree on an age of the skeletons, an adult male and a six to seven year old child, because they were discovered in deposits of slumped loess, confusing the geological picture. Hrdli?ka states that the skeletons were physically identical to Indians of that region at the period of historical contact. William Holmes had the skull sent to the U. S. National Museum and the remaining bones were placed in the Museum of Natural History at the University of Kansas. While on the staff of the University of Kansas, I had Carbon-14 tests conducted on bones from the lower limbs by three separate laboratories. These dates range from 2660 to 5020 B.C. with an average date of four samples (1 each from Geochron Laboratories and the University of Michigan and two from the Smithsonian Institution) of 3579 B.C. This suggests that the “Lansing Man” skeletons are Early Middle Archaic and not Paleoindian. They do, however, represent the oldest known human skeletons from Kansas.     

端粒和端粒酶的发现及其生物学意义

2009年的诺贝尔生理学或医学奖授予了美国加州大学旧金山分校的Elizabeth H．Blackburn、约翰霍普金斯大学的Carol W．Greider以及哈佛医学院的Jack W．Szostak三位科学家,肯定他们在发现端粒以及端粒酶保护染色体末端方面所做出的贡献。端粒以及端粒酶的发现历经近半个世纪,追溯起端粒和端粒酶的整个发现过程,却是耐人寻味,给人启发。端粒是真核生物中位于染色体末端的DNA和蛋白质的复合物,它对于维持基因组的完整性以及染色体的稳定性都有着至关重要的作用。端粒DNA可以被一种特化的称为“端粒酶”的逆转录酶延伸。端粒长度的维持以及端粒结构的稳定在细胞衰老、癌症发生以及干细胞全能性自我更新能力维持等生命过程中都起重要作用。     

A Love Affair with Bacillus subtilis

My career in science was launched when I was an undergraduate at Princeton University and reinforced by graduate training at the Massachusetts Institute of Technology. However, it was only after I moved to Harvard University as a junior fellow that my affections were captured by a seemingly mundane soil bacterium. What Bacillus subtilis offered was endless fascinating biological problems (alternative sigma factors, sporulation, swarming, biofilm formation, stochastic cell fate switching) embedded in a uniquely powerful genetic system. Along the way, my career in science became inseparably interwoven with teaching and mentoring, which proved to be as rewarding as the thrill of discovery.     

植物抗冻蛋白研究进展

抗冻蛋白(AFPs)最初是从极区海鱼中发现的一种适应低温的特异蛋白质, 它能阻止体液内冰核的形成与生长,维持体液的非冰冻状态.对近年来植物AFPs的发现过程,AFP的生化特性,抗冻作用机制,抗冻蛋白基因工程及其应用前景等作了系统的综述.     

The Last Month of Szent-Györgyi in Groningen

Albert (von) Szent-Györgyi started his studies on biological oxidation processes – which also resulted in the discovery of vitamin C, for which he received the Nobel Price in 1937 – in the Laboratory of Physiology of the University in Groningen in 1922–1926. These studies were later continued in Cambridge (UK) and Szeged (Hungary). When he had already received the invitation as well as the financial means to come and work in Cambridge, he still did experiments in Groningen to find out whether the adrenal extract, isolated by him and later found to be a major source of vitamin C, contained the hormone essential for the survival of cats whose adrenals were removed. He was rather upset by the negative results of this experiment, judging by the recollections of a former student of his. This history constitutes an interesting example of the difference between serendipitous discovery and planned invention.     

类异戊二烯非甲羟戊酸代谢途径的分子生物学研究进展

近期发现的类异戊二烯非甲羟戊酸代谢途径是类异戊二烯化合物生成合成的另一途径。文章对该代谢途径的分子生物学研究进展进行了综述。重点介绍非甲羟戊酸代谢途径的发现和5－磷酸脱氧木糖合成酶、5－磷酸脱氧木糖还原异构醇、异戊二烯焦磷酸合成酶的分子克隆的最新进展以及非甲羟戊酸代谢途径的发现在农业和医药等领域的应用。     

Molecular polymorphism: How much is there and why is there so much?

The evidence for genetic variation can be traced to Mendel's experiments: The discovery of the laws of heredity was made possible by the expression of segregating alleles. Since that time, the study of genetic variation in natural populations has been characterized by a gradual discovery of ever-increasing amounts of genetic variation. In the early decades of this century geneticists thought that an individual is homozygous at most gene loci and that individuals of the same species are genetically almost identical. Recent discoveries suggest that, at least in outcrossing organisms, the DNA sequences inherited one from each parent are likely to be different for nearly every gene locus in every individual; ie, that every individual may be heterozygous at most, if not all, gene loci. But the efforts to obtain precise estimates of genetic variation have been thwarted for various reasons.     

水通道的生物学研究

美国约翰·霍普金斯大学生化教授彼得·埃格瑞博士,他被瑞典皇家科学院授予2003年诺贝尔化学奖,以承认他们的实验室在1991年发现的水通道。水通道或称水孔蛋白的发现为这类蛋白的生化学、生理学和遗传学开创了一个黄金时代。 现在已鉴定了10余种哺乳动物水通道,每种都有其特定的组织分布。在肾脏、肺、眼和脑等组织表达多种水通道,构成水转运的网络。已确定水孔蛋白的基本结构是在细胞膜中以四聚体的形式存在。水通道参与许多临床疾病,包括尿崩症到各种形式水肿的病生理学过程。它们可能是治疗水平衡紊乱性疾病的靶。     

Resurrections in Toronto: the emergence of insulin

The discovery of insulin remains the greatest and one of the most controversial events in the history of endocrinology. Hypotheses about the possible existence of an internal secretion of the pancreas date from the early 1890s and were steadily modified with the development of the concept of an endocrine system. In the spring of 1922, after many false starts and dead ends, a team of researchers at the University of Toronto provided conclusive evidence of the existence of the internal secretion of insulin. The discovery process was fraught with personal and scientific rivalries more striking than fiction. The early use of insulin on starved, dying diabetic children awed everyone involved in the process. With the discovery of insulin, endocrinology moved into the mainstream of medical science.     

Synthesis,pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease

The cholinergic hypothesis has long been a “polar star” in drug discovery for Alzheimer’s disease (AD), resulting in many small molecules and biological drug candidates. Most of the drugs marketed for AD are cholinergic. Herein, we report our efforts in the discovery of cholinesterases inhibitors (ChEIs) as multi-target-directed ligands. A series of tacrine-ferulic acid hybrids have been designed and synthesised. All these compounds showed potent acetyl-(AChE) and butyryl cholinesterase(BuChE) inhibition. Among them, the optimal compound 10g, was the most potent inhibitor against AChE (electrophorus electricus (eeAChE) half maximal inhibitory concentration (IC₅₀)?=?37.02?nM), it was also a strong inhibitor against BuChE (equine serum (eqBuChE) IC₅₀?=?101.40?nM). Besides, it inhibited amyloid β-protein self-aggregation by 65.49% at 25?μM. In subsequent in vivo scopolamine-induced AD models, compound 10g obviously ameliorated the cognition impairment and showed preliminary safety in hepatotoxicity evaluation. These data suggest compound 10g as a promising multifunctional agent in the drug discovery process against AD.     

Q & A. Carl R. Woese. [interview

Carl R. Woese was born and raised in Syracuse, New York. His undergraduate training was at Amherst College (AB 1950) and graduate work at Yale University (PhD 1953). He is currently the Stanley O. Ikenberry University Professor and Center for Advanced Study Professor of Microbiology at the University of Illinois (Champaign-Urbana), where he has been for the past forty years. He was trained as a biophysicist and molecular biologist. He views himself as a molecular biologist in search of Biology. Consequently, his career has been devoted to using molecular methods to approach evolutionary problems. His most notable accomplishments have been determining the universal phylogenetic tree, through molecular sequence analysis, and the discovery of the Archaea, the so-called ‘third form’ of life. For these he has received numerous awards, including a John D. and Catherine T. MacArthur Award, the Leeuwenhoek Medal 1990 (Netherlands Royal Academy), the Waksman Award (National Academy of Science USA), and the Crafoord Prize (Swedish Royal Academy). At present he works on the evolution of cellular organization.     

虚拟筛选与新药发现

虚拟筛选是创新药物研究的新方法和新技术,近年来引起了研究机构和制药公司的高度重视,并且已经成为一种与高通量筛选互补的实用化工具,加入到了创新药物研究的工作流程(pipeline)中。本文介绍国际上虚拟筛选及其在创新药物发现中应用的研究进展,特别介绍了我国这方面研究的状况。     

Origins of cancer therapy

This is a brief overview of the development of cancer therapy with a focus on systemic therapy. The modern era of chemotherapy developed at Yale University Medical School during World War II, a fact that has been generally unrecognized until recently. The observations preceding and involved in the discovery of effective drugs for cancer seem particularly pertinent for this anniversary year.     

A molecular view of cytotoxic T lymphocyte induced killing.

Cytotoxic T lymphocytes (CTLs) search out and destroy pathogenic cells, such as those infected with viruses. The biochemistry laboratory at the University of Alberta (Edmonton, Alta.) studies the molecular mechanisms used by these effectors, and this review covers research on this topic primarily from this group. Research there began with the discovery of the granzyme genes and the realization that granzyme B (GrB) had an unusual substrate specificity. Cleavage at aspartate residues gave us the clue that caspases, key regulators of apoptosis, were important substrates. However, it is now clear that mitochondria are also important in controlling granzyme-induced apoptosis. This led to the discovery that the proapoptotic member of the Bcl2 family, Bid, is also activated by GrB. Cleaved Bid then translocates to the mitochondria, resulting in the release of antagonists of inhibitors of apoptosis proteins. The evolution of our understanding of the molecular basis of CTL killing is presented.     

In silico screening and identification of potential GSK3β inhibitors

Abstract

Glycogen synthase kinase-3β (GSK3β) has been reported for its impact on multitude biological processes from cell proliferation to apoptosis. The increase in the ratio of active/inactive GSK3β is the major factor associated in the etiology of several psychiatric diseases, diabetes, muscle hypertrophy, neurodegenerative diseases, and some cancers. These findings made GSK3β a promising therapeutic target, and the interest in the discovery, synthesis of novel drugs to effectively attenuate its function with probably no side effects has been increasing in the chronology of GSK3β drug discovery. In the present study, we applied a combination of computational tools on a chemical library for the virtual discovery of their potency to inhibit GSK3β. The chemical library was screened against a set of filters at different levels. Finally, five compounds in the chemical library were found to potentially inhibit GSK3β with no toxic effects. Furthermore, binding mode analysis revealed that all the compounds bound to the ATP site and most of the hydrogen bonding interactions are conserved as in GSK3β structures deposited in PDB.     

Nutrition proteomics and biomarker discovery

Baukje de Roos is a principal investigator at the University of Aberdeen, Rowett Institute of Nutrition and Health. She investigates mechanisms through which dietary fats and fatty acids, and also polyphenols, affect parameters involved in the development of heart disease in vivo. This is achieved not only by measuring their effect on conventional risk markers for heart disease but also by assessing their effect on new markers that are being developed through proteomic and mass spectrometry methods. She obtained her PhD in Human Nutrition at Wageningen University, The Netherlands, in January 2000, after which she was appointed as a post-doctoral research fellow at the Department of Vascular Biochemistry, Glasgow Royal Infirmary, in collaboration with GlaxoSmithKline. In June 2001 she joined the Rowett Research Institute in Aberdeen. She is currently working for the University of Aberdeen, where her research is funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). She is an active member of the European Nutrigenomics Organisation (NuGO), an EU-funded Network of Excellence, which merges the nutrigenomics activities of its 23 partners across Europe.